Daito Pharmaceutical Co.,Ltd.

Simbol: 4577.T

JPX

2540

JPY

Tržna cena danes

  • 12.0844

    Razmerje P/E

  • -0.4769

    Razmerje PEG

  • 39.73B

    Kapaciteta MRK

  • 0.02%

    Donos DIV

Daito Pharmaceutical Co.,Ltd. (4577-T) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Daito Pharmaceutical Co.,Ltd. (4577.T). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Daito Pharmaceutical Co.,Ltd., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

balance-sheet.row.cash-and-short-term-investments

0360743813372.9
3084.1
1819.4
1711.4
1617.3
1351.1
1918.7
2513
4149.1
1572.2
1757.7
2611.4
1162.9

balance-sheet.row.short-term-investments

0-205-206-294.2
-249.5
-240
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

010670105858382
9065.5
9394.7
9497.5
9901.9
9275
10322.6
10064.7
9610.1
8767.5
8366.2
7149.8
7003

balance-sheet.row.inventory

0182381682015751.7
12130.7
10059.1
9308.6
8493
6984
5352.3
4436.5
4018
3418.7
3485.7
2909.7
3098.5

balance-sheet.row.other-current-assets

0814861234923.3
6574.8
3087.3
4538.8
4333.5
4470.7
4123.1
3046.2
755.1
427.2
350.5
213.9
167.5

balance-sheet.row.total-current-assets

0406633790932429.9
30855.2
24360.5
25056.3
24345.7
22080.8
21716.8
20060.4
18532.2
14185.6
13960.1
12884.8
11431.9

balance-sheet.row.property-plant-equipment-net

0258372311621372
19399.6
18732.1
18654.2
17878.4
17446.9
16440.6
13445.1
12992
13329.9
12722.8
12533
12750.1

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
2

balance-sheet.row.intangible-assets

0377386332.7
299.4
306.5
330
321.9
400.1
521.9
588.2
558.3
483.6
285.6
165.4
155.3

balance-sheet.row.goodwill-and-intangible-assets

0377386332.7
299.4
306.5
330
321.9
400.1
521.9
588.2
558.3
483.6
285.6
165.4
157.3

balance-sheet.row.long-term-investments

0316929583096
3393
3020
2877.5
2829
3087.8
3358.5
2332
2326.2
1429.7
1628.5
1736.3
1609.2

balance-sheet.row.tax-assets

0504570508
302.3
329.8
32.9
31
30.9
32.8
52.1
34.4
67.2
77.6
16.4
16.9

balance-sheet.row.other-non-current-assets

00-10.7
0.3
0.2
245.2
301.8
293.7
234.7
216.9
319.1
413.5
397.4
379.8
388.2

balance-sheet.row.total-non-current-assets

0298872702925309.5
23394.6
22388.5
22139.8
21362.2
21259.4
20588.4
16634.3
16230.1
15724
15111.9
14830.9
14921.5

balance-sheet.row.other-assets

0210
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0705526493957739.4
54249.7
46749.1
47196.1
45707.9
43340.2
42305.2
36694.7
34762.3
29909.5
29072
27715.8
26353.4

balance-sheet.row.account-payables

0443544934359.6
4330.4
4086.2
3620.6
3587
3644.3
4176.8
3445.4
3185.9
3458
3530.8
3041.5
3248.1

balance-sheet.row.short-term-debt

0151312001375.1
1782.3
2319.1
4036.3
5937.8
8566.2
8567.5
9094
8948.8
6184.4
6031.5
6578.6
5542.7

balance-sheet.row.tax-payables

055914021098.5
1302.7
351.9
729.3
1022.1
366.9
821.8
666
293
609.8
531.8
199
358.9

balance-sheet.row.long-term-debt-total

0344522472018.9
1582.7
3098.1
4027.9
3712
3692.2
3492
4474.8
5346.3
5547
6016
5946.7
7988.5

Deferred Revenue Non Current

0507755764.3
568.2
506.1
514.4
484.7
455.4
195.9
227.4
207.8
258.4
333.9
391.9
452.8

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0410138873399.9
4410
2761.9
5297.3
2349
812.6
614.1
639.4
64
1457.3
1362.1
993.8
1108.6

balance-sheet.row.total-non-current-liabilities

0415331992963.2
2327
3781.9
5017
4659
4713.9
4464.6
5203.5
6063.8
6178
6754.5
6766.5
8849.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

09201.5
4.5
9.1
17.5
32.4
65.1
286.2
536.2
904.8
1205.9
1550.2
1662.4
1790.3

balance-sheet.row.total-liab

0195811726815822
17381.4
15399.7
18700.6
19894
19779.9
20450.5
20070.1
19688.6
18392.9
18704.1
18071.7
19638.4

balance-sheet.row.preferred-stock

049141462730
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0718670316271.2
5370.2
4367.8
4367.8
4367.8
4367.8
4367.8
3120.3
3120.3
2565.1
2565.1
2565.1
1437.5

balance-sheet.row.retained-earnings

0350063233828331.6
24742.9
21301.6
18239.1
15610.1
13329.3
11138.3
9342.8
7828
6310.1
5100.1
4288.6
3644

balance-sheet.row.accumulated-other-comprehensive-income-loss

015311031872.4
1153.1
1031.9
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0-42192-393696143.7
5243
4240.7
5453.4
5388.2
5460.6
5954.4
3814.5
3802.1
2641.5
2702.7
2790.3
1633.4

balance-sheet.row.total-stockholders-equity

0506724730441619
36509.2
30942
28060.3
25366.1
23157.6
21460.5
16277.6
14750.4
11516.7
10367.8
9644
6714.9

balance-sheet.row.total-liabilities-and-stockholders-equity

0705526493957739.4
54249.7
46749.1
47196.1
45707.9
43340.2
42305.2
36694.7
34762.3
29909.5
29072
27715.8
26353.4

balance-sheet.row.minority-interest

0299367298.4
359.1
407.3
435.2
447.7
402.7
394.1
347
323.3
0
0
0
0

balance-sheet.row.total-equity

0509714767141917.4
36868.4
31349.4
28495.6
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0296427522801.8
3143.5
2780
2877.5
2829
3087.8
3358.5
2332
2326.2
1429.7
1628.5
1736.3
1609.2

balance-sheet.row.total-debt

0495834473394
3365
5417.2
8064.2
9649.8
12258.4
12059.5
13568.7
14295.1
11731.4
12047.6
12525.3
13531.2

balance-sheet.row.net-debt

01351-93421.1
280.9
3597.8
6352.8
8032.4
10907.3
10140.8
11055.7
10146
10159.2
10289.9
9913.8
12368.3

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Daito Pharmaceutical Co.,Ltd. opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

cash-flows.row.net-income

0507667205873.9
5595.2
4618.8
4263.1
3885.2
3426.1
3372.8
2869.4
2608
2454.7
1678.1
1268
1169.2

cash-flows.row.depreciation-and-amortization

0387033133154.3
2950.5
2852.5
2853.2
2818.2
2643.2
2439.9
2444.8
2569.4
2269.2
2093
1952.9
1745.2

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-2326-4399-1582.4
-4220.2
538.4
392
-2127.7
-1824
-817.1
-1911.5
-1283.7
-678.4
-793.4
-637.2
-1998.6

cash-flows.row.account-receivables

0-1502-32992723
-3369
947
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-1413-1041-3609.2
-2075.5
-751
-815.1
-1508.8
-1631.7
-915.8
-418.5
-599.3
54.3
-576
188.8
231.6

cash-flows.row.account-payables

053822-765.1
1229.3
335
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

051-8169
-5
7.3
1207.1
-618.9
-192.3
98.7
-1493
-684.4
-732.7
-217.5
-825.9
-2230.2

cash-flows.row.other-non-cash-items

0-2465-1264-2263.3
-19.2
-1121.5
-2042.8
494
-1296.4
-1256.3
-658.1
-1352.3
-702.6
-148.5
-416.5
105.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-5556-4733-6349.6
-2773.3
-3662.8
-3873.7
-2992.2
-3948.6
-4919.1
-2334.9
-1859
-2936.1
-3066.7
-1250.3
-4656.6

cash-flows.row.acquisitions-net

00680
-42.1
0
0
0
0
28.9
0.6
62
21.4
0.7
1.2
0.5

cash-flows.row.purchases-of-investments

00-680
-77.8
-212.4
-12.5
0
-49
-37.4
-791.5
-665
-11
-81.9
-93.6
-326.6

cash-flows.row.sales-maturities-of-investments

002565
175.3
0
0
0
7.7
384.7
1123.2
183.8
2
1.4
7.1
19.2

cash-flows.row.other-investing-activites

0-107720.3
36.5
7.7
53.1
-19.7
-25.3
-51.6
-160.1
41.2
-255.4
-188.6
62.6
-69.5

cash-flows.row.net-cash-used-for-investing-activites

0-5566-4400-6324.3
-2681.4
-3867.4
-3833.1
-3011.8
-4015.2
-4594.5
-2162.7
-2237
-3179.1
-3335.2
-1273.2
-5033

cash-flows.row.debt-repayment

0-1638-1444-1712.4
-1851.9
-2038.5
-2265.3
-2335.5
-2622.3
-2632.1
-2768.7
-2905.2
-2712.9
-2637.4
-2777.5
-2108.2

cash-flows.row.common-stock-issued

030815141798.5
2000.5
-408.4
0
97.8
72.9
2475.4
999.3
1098.9
2547.7
2467.3
2228.4
2120.8

cash-flows.row.common-stock-repurchased

0-1161499-0.3
-0.2
-0.4
-1
-0.7
-2.3
-8.3
-0.1
0
-0.1
-0.2
1303.7
2570.7

cash-flows.row.dividends-paid

0-931-660-658.1
-502.1
-450.7
-412.6
-375.3
-374.6
-466.2
-296
-267.8
-178.8
-178.8
-107.8
-40.4

cash-flows.row.other-financing-activites

02993801997
3.2
0
1135.3
835.9
3452.6
1134
0
3764.5
0
0
0
1630.4

cash-flows.row.net-cash-used-provided-by-financing-activities

06169891424.8
-350.5
-2898.1
-1543.6
-1777.7
526.3
502.9
-2065.4
1690.5
-344.1
-349.1
646.8
4173.3

cash-flows.row.effect-of-forex-changes-on-cash

020485.8
-9.7
-14.6
5.4
-14
-27.6
-14.6
70.5
131.5
1.3
-0.5
-0.4
-0.2

cash-flows.row.net-change-in-cash

0-7741009288.8
1264.7
108
94.1
266.2
-567.6
-366.9
-1412.9
2126.4
-179
-855.7
1540.5
161

cash-flows.row.cash-at-end-of-period

0360743813372.9
3084.1
1819.4
1711.4
1617.3
1351.1
1918.7
2285.7
3698.6
1572.2
1751.2
2606.9
1066.4

cash-flows.row.cash-at-beginning-of-period

0438133723084.1
1819.4
1711.4
1617.3
1351.1
1918.7
2285.7
3698.6
1572.2
1751.2
2606.9
1066.4
905.4

cash-flows.row.operating-cash-flow

0415543705182.5
4306.3
6888.2
5465.3
5069.7
2948.9
3739.3
2744.7
2541.4
3342.9
2829.1
2167.2
1020.9

cash-flows.row.capital-expenditure

0-5556-4733-6349.6
-2773.3
-3662.8
-3873.7
-2992.2
-3948.6
-4919.1
-2334.9
-1859
-2936.1
-3066.7
-1250.3
-4656.6

cash-flows.row.free-cash-flow

0-1401-363-1167
1533
3225.4
1591.7
2077.6
-999.8
-1179.8
409.8
682.4
406.8
-237.7
916.9
-3635.7

Vrstica izkaza poslovnega izida

Prihodki Daito Pharmaceutical Co.,Ltd. so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja 4577.T znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

income-statement-row.row.total-revenue

0451014346448709.2
44997.1
41135.1
39883.6
37973.4
36331.2
34062.4
31202.2
28959.2
27149.4
25218.4
22679.5
21460.7

income-statement-row.row.cost-of-revenue

0347703200537917.3
35512.6
32463.3
31765.4
30232.3
29104.4
26990.4
25213.1
23031.1
21491.1
20518.2
18982.9
17937.1

income-statement-row.row.gross-profit

0103311145910791.9
9484.5
8671.7
8118.2
7741.1
7226.8
7072
5989.1
5928.1
5658.3
4700.2
3696.6
3523.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

033728.4
28.8
28.3
25.8
47.9
42.7
40
30
25.9
97.6
80.4
23
52

income-statement-row.row.operating-expenses

0512349054883.1
4127.2
4124.4
3957.1
3908.9
3670.9
3553
3050.2
3249.2
3031.7
2741.4
2245.7
2185.1

income-statement-row.row.cost-and-expenses

0398933691042800.3
39639.8
36587.7
35722.5
34141.2
32775.3
30543.4
28263.3
26280.3
24522.9
23259.5
21228.6
20122.2

income-statement-row.row.interest-income

045460.4
0.5
1.4
0.7
0.7
0.7
12.8
10.4
0.1
0.1
0.1
0.2
7.6

income-statement-row.row.interest-expense

01297.8
11.9
20.9
24.1
28.6
39.6
58.4
87.1
126.3
158.1
182.3
219.9
210.1

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-135152-43
233
72
101.9
53
-129.8
-146.1
-69.5
-70.9
-171.9
-280.8
-182.9
-169.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

033728.4
28.8
28.3
25.8
47.9
42.7
40
30
25.9
97.6
80.4
23
52

income-statement-row.row.total-operating-expenses

0-135152-43
233
72
101.9
53
-129.8
-146.1
-69.5
-70.9
-171.9
-280.8
-182.9
-169.3

income-statement-row.row.interest-expense

01297.8
11.9
20.9
24.1
28.6
39.6
58.4
87.1
126.3
158.1
182.3
219.9
210.1

income-statement-row.row.depreciation-and-amortization

0387033133154.3
2950.5
2852.5
2853.2
2818.2
2643.2
2439.9
2444.8
2569.4
2269.2
2093
1952.9
1745.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0520765535908.8
5357.3
4547.3
4161.2
3832.2
3555.8
3519
2938.9
2678.9
2626.6
1958.9
1450.9
1338.5

income-statement-row.row.income-before-tax

0507667205873.9
5595.2
4618.8
4263.1
3885.2
3426.1
3372.8
2869.4
2608
2454.7
1678.1
1268
1169.2

income-statement-row.row.income-tax-expense

0154920921716.9
1670.4
1122.4
1250.6
1258.2
878.7
1136.4
1064.7
821.9
1065.5
687.4
515.6
476.2

income-statement-row.row.net-income

0360046684246
3944.7
3513
3041.9
2656.3
2566.4
2246.1
1811.4
1786.6
1389.1
990.6
752.4
693

Pogosto zastavljeno vprašanje

Kaj je Daito Pharmaceutical Co.,Ltd. (4577.T) skupna sredstva?

Daito Pharmaceutical Co.,Ltd. (4577.T) skupna sredstva so 70552000000.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.214.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je 346.005.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je 0.073.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so 0.093.

Kaj je Daito Pharmaceutical Co.,Ltd. (4577.T) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je 3600000000.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 4958000000.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 5123000000.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.